Cerezyme Dosage & Drug Information

Concise Prescribing Info

Contents

Imiglucerase

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Indications/Uses

Long-term enzyme replacement therapy in patients w/ confirmed diagnosis of non-neuronopathic (Type 1) or chronic neuronopathic (Type 3) Gaucher disease who exhibit clinically significant non-neurological manifestations including anemia after exclusion of other causes (eg, Fe deficiency), thrombocytopenia, bone disease after exclusion of other causes (eg, vit D deficiency), hepatomegaly or splenomegaly.

Dosage/Direction for Use

IV Individualised dosage. Initially 15 u/kg to 60 u/kg once every 2 wk. Administer at 0.5 u/kg/min initial infusion. May be increased at subsequent administrations. Max: 1 u/kg/min.

Contraindications

Hypersensitivity.

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

A16AB02 - imiglucerase ; Belongs to the class of enzymes. Used in the treatment of alimentary tract and metabolism problems.

Regulatory Classification

POM

Presentation/Packing

Form

Cerezyme powd for inj 400 u

Packing/Price

1's

Cerezyme

imiglucerase

Manufacturer:

sanofi-aventis